Welcome to our dedicated page for ICON PLC SEC filings (Ticker: ICLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ICON PLC’s SEC reports can feel as dense as a clinical trial protocol—buried inside the 10-K are pages on backlog conversion rates, post-acquisition synergies, and laboratory service margins. Hunting for a single note on patient-recruitment risk or integration costs consumes precious time. Stock Titan’s platform surfaces the answers instantly, giving you an AI-powered shortcut to ICON PLC SEC filings explained simply.
Whether you need an ICON PLC annual report 10-K simplified to spot goodwill impairment triggers, or an ICON PLC quarterly earnings report 10-Q filing to track revenue by Phase III study, every document arrives in real time from EDGAR. Our AI breaks down:
- Form 4 insider transactions—get ICON PLC Form 4 insider transactions real-time alerts and visualize buying or selling before key data readouts.
- 8-K material events—see “ICON PLC 8-K material events explained”, from large contract wins to unexpected trial discontinuations.
- Proxy statements—quickly compare ICON PLC proxy statement executive compensation against peer CROs.
Practical use cases follow naturally: monitor ICON PLC executive stock transactions Form 4 ahead of earnings, compare backlog growth quarter-over-quarter, or gauge acquisition integration costs without wading through footnotes. From "understanding ICON PLC SEC documents with AI" to "ICON PLC earnings report filing analysis", Stock Titan equips life-sciences investors with clear summaries, expert context, and searchable, always-current filings—so you can focus on decisions, not document hunts.
ICON plc (ICLR) insider filed a Form 144 to sell 18,901 common shares with an aggregate market value of $3,594,781.19. The shares are scheduled for sale on or about 10/02/2025 on NASDAQ.
The filing shows the 18,901 shares were acquired on 10/01/2025 as restricted stock that vested under a registered plan and were issued by the issuer for services rendered. The filing reports 77,772,130 shares outstanding and indicates no securities sold by the filer in the past three months.
Artisan Partners filed Amendment No. 1 to a Schedule 13G reporting a beneficial ownership position in ICON plc Ordinary Shares (CUSIP G4705A100). The filing discloses ownership of 7,184,870 shares, equal to 9.0% of the class based on 79,483,795 shares outstanding as of 06/05/2025. The reporting group reports no sole voting or dispositive power, shared voting power of 6,946,790 and shared dispositive power of 7,184,870.
The statement notes that 5,518,132 of the shares are held on behalf of Artisan Funds and that the shares were acquired on behalf of discretionary clients of Artisan Partners Limited Partnership. The filing certifies the holdings are in the ordinary course of business and not intended to change control and is signed by Gregory K. Ramirez. A joint filing agreement is included as an exhibit.
Icon Plc (ICLR) submitted a Form 144 notice reporting a proposed sale of 381 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $59,992.98. The form lists 77,772,130 shares outstanding and shows the shares were acquired on 08/07/2025 by restricted stock vesting under a registered plan and are to be sold on or about 08/08/2025. The filing reports Nothing to Report for securities sold in the past three months.
The notice includes the filer’s representation that they are unaware of undisclosed material adverse information. Several issuer/filer identification fields in the form are left blank in the provided content.
Icon Plc filed a Rule 144 notice proposing the sale of 1,136 common shares with an aggregate market value of $178,876.72. The sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ with an approximate sale date of 08/08/2025. The filing reports 77,772,130 shares outstanding, giving context to the size of this proposed transaction.
The securities were acquired on 08/07/2025 as restricted stock vesting under a registered plan from the issuer and the stated nature of payment is services rendered. The filer reports nothing to report for securities sold during the past three months and includes the standard representation that the signer knows of no undisclosed material adverse information about the issuer.